A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer. Langbein BJ, Berk B, Bay C, Tuncali K, et al. Urology 2024 Jan 11:S0090-4295(23)01122-6. doi: 10.1016/j.urology.2023.

Read + Share

Amedeo Smart

Independent Medical Education

Langbein BJ, Berk B, Bay C, Tuncali K, et al. A Phase II Prospective Blinded Trial of MRI and In-Bore Biopsy in Active Surveillance for Prostate Cancer. Urology 2024 Jan 11:S0090-4295(23)01122-6. doi: 10.1016/j.urology.2023.
PMID: 38218388